Moreover, Ahsg, in conjunction with the chemokine CXCL12 (also called stromal-derived factor-1 (SDF-1)), has been shown to enhance chemotaxis in in vitro studies of breast cancer cells [31]. This evidence concerns the gene CXCL12 and breast carcinoma.